Suppr超能文献

国际质量改进协作导管插入术登记处的初步经验。

Pilot phase experience of the International Quality Improvement Collaborative catheterization registry.

机构信息

Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.

Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan.

出版信息

Catheter Cardiovasc Interv. 2021 Jan 1;97(1):127-134. doi: 10.1002/ccd.28908. Epub 2020 Apr 15.

Abstract

OBJECTIVES

To describe the development of a quality collaborative for congenital cardiac catheterization centers in low and middle-income countries (LMICs) including pilot study data and a novel procedural efficacy measure.

BACKGROUND

Absence of congenital cardiac catheterization registries in LMICs led to the development of the International Quality Improvement Collaborative Congenital Heart Disease Catheterization Registry (IQIC-CHDCR). As a foundation for this initiative, the IQIC is a collaboration of pediatric cardiac surgical programs from LMICs. Participation in IQIC has been associated with improved patient outcomes.

METHODS

A web-based registry was designed through a collaborative process. A pilot study was conducted from October through December 2017 at seven existing IQIC sites. Demographic, hemodynamic, and adverse event data were obtained and a novel tool to assess procedural efficacy was applied to five specific procedures. Procedural efficacy was categorized using ideal, adequate, and inadequate.

RESULTS

A total of 429 cases were entered. Twenty-five adverse events were reported. The five procedures for which procedural efficacy was measured represented 48% of cases (n = 208) and 71% had complete data for analysis (n = 146). Procedure efficacy was ideal most frequently in patent ductus arteriosus (95%) and atrial septal defect (90%) device closure, and inadequate most frequently in coarctation procedures (100%), and aortic and pulmonary valvuloplasties (50%).

CONCLUSIONS

The IQIC-CHDCR has designed a feasible collaborative to capture catheterization data in LMICs. The novel tool for procedural efficacy will provide valuable means to identify areas for quality improvement. This pilot study and lessons learned culminated in the full launch of the IQIC-CHDCR.

摘要

目的

描述一个先天性心脏病导管插入术中心质量合作组织(LMIC)的发展,包括试点研究数据和一种新的程序功效衡量标准。

背景

由于缺乏先天性心脏病导管插入术登记处,导致了国际质量改进合作先天性心脏病导管插入术登记处(IQIC-CHDCR)的发展。作为该倡议的基础,IQIC 是来自 LMIC 的儿科心脏外科项目的合作。参与 IQIC 与改善患者预后相关。

方法

通过协作过程设计了一个基于网络的登记处。在 2017 年 10 月至 12 月期间,在七个现有 IQIC 地点进行了试点研究。获得了人口统计学、血液动力学和不良事件数据,并应用了一种新的工具来评估程序功效,对五个具体程序进行评估。程序功效分为理想、充分和不充分。

结果

共输入 429 例。报告了 25 例不良事件。对五个程序进行了程序功效评估,占病例总数的 48%(n = 208),有完整数据进行分析的占 71%(n = 146)。最常见的是动脉导管未闭(95%)和房间隔缺损(90%)装置闭合的理想程序功效,最常见的是缩窄术(100%)和主动脉瓣和肺动脉瓣成形术(50%)的不充分程序功效。

结论

IQIC-CHDCR 设计了一个可行的合作,以在 LMIC 中捕获导管插入术数据。新的程序功效工具将提供有价值的方法来确定质量改进的领域。这项试点研究和经验教训最终导致 IQIC-CHDCR 的全面推出。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验